In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents
- PMID: 984777
- PMCID: PMC429749
- DOI: 10.1128/AAC.10.2.370
In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents
Abstract
Six pathogenic strains of Naegleria fowleri, two of Acanthamoeba castellanii, and three of Acanthamoeba polyphaga were tested in vitro for susceptibility to a variety of potentially useful therapeutic agents. Minimal motility inhibitory concentrations and minimal inhibitory concentrations were determined by a technique of subculturing pure clones of amoebae in plastic tissue culture chamber slides containing liquid axenic media and serially diluted drug, incubating at 30 degrees C for Acanthamoeba and at 37 degrees C for Naegleria, and observing on an inverted microscope at 6 h for inhibition of motility and at 24 and 48 h for inhibition of growth. Drug concentrations were selected on the basis of fluid levels achievable in humans. Amphotericin B, clotrimazole, and miconazole were the most effective drugs against Naegleria, whereas polymyxin B sulfate and pentamidine isethionate were somewhat effective against pathogenic Acanthamoeba. Our results suggest that amphotericin B is the most effective agent against Naegleria, but few agents are effective against Acanthamoeba.
Similar articles
-
Efficient Liquid Media for Encystation of Pathogenic Free-Living Amoebae.Korean J Parasitol. 2017 Jun;55(3):233-238. doi: 10.3347/kjp.2017.55.3.233. Epub 2017 Jun 30. Korean J Parasitol. 2017. PMID: 28719947 Free PMC article.
-
The effects of some factors on the growth and morphology of Naegleria sp. and three strains of the genus Acanthamoeba.Folia Parasitol (Praha). 1975;22(4):317-21. Folia Parasitol (Praha). 1975. PMID: 4366
-
Chemotherapeutic compounds and Acanthamoebae from eye infections.J Clin Pathol. 1976 Jul;29(7):648-51. doi: 10.1136/jcp.29.7.648. J Clin Pathol. 1976. PMID: 185240 Free PMC article.
-
Opportunistic amoebae: challenges in prophylaxis and treatment.Drug Resist Updat. 2004 Feb;7(1):41-51. doi: 10.1016/j.drup.2004.01.002. Drug Resist Updat. 2004. PMID: 15072770 Review.
-
Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.FEMS Immunol Med Microbiol. 2007 Jun;50(1):1-26. doi: 10.1111/j.1574-695X.2007.00232.x. Epub 2007 Apr 11. FEMS Immunol Med Microbiol. 2007. PMID: 17428307 Review.
Cited by
-
Differential Growth Rates and In Vitro Drug Susceptibility to Currently Used Drugs for Multiple Isolates of Naegleria fowleri.Microbiol Spectr. 2022 Feb 23;10(1):e0189921. doi: 10.1128/spectrum.01899-21. Epub 2022 Feb 9. Microbiol Spectr. 2022. PMID: 35138140 Free PMC article.
-
Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro.ACS Chem Neurosci. 2020 Aug 19;11(16):2464-2471. doi: 10.1021/acschemneuro.0c00165. Epub 2020 May 26. ACS Chem Neurosci. 2020. PMID: 32392039 Free PMC article.
-
In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B.Int J Parasitol Drugs Drug Resist. 2017 Dec;7(3):328-336. doi: 10.1016/j.ijpddr.2017.09.002. Epub 2017 Sep 8. Int J Parasitol Drugs Drug Resist. 2017. PMID: 28918001 Free PMC article.
-
In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination.Antimicrob Agents Chemother. 1979 Aug;16(2):217-20. doi: 10.1128/AAC.16.2.217. Antimicrob Agents Chemother. 1979. PMID: 485131 Free PMC article.
-
Opportunistic free-living amoebal pathogens.Pathog Glob Health. 2022 Mar;116(2):70-84. doi: 10.1080/20477724.2021.1985892. Epub 2021 Oct 2. Pathog Glob Health. 2022. PMID: 34602025 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources